SANA

Sana Biotechnology Inc.

Price

$4.10

return (12m)

18.50%

p/e

-4.81

p/bv

6.59

DIVIDEND YIELD

0.00%

SANA price

Sana Biotechnology

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SANA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

27.33%

3 months

30.16%

1 year

18.50%

2 years

-18.65%

5 years

-81.78%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SANA

Valuation

P/E

-4.81

Sector -4.38

Industry -4.38

P/BV

6.59

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-13.57

Sector -263.09

Industry -263.09

EV/EBIT

-13.11

Sector -702.90

Industry -702.90

P/EBITDA

-4.90

Sector -4.39

Industry -4.39

P/EBIT

-4.65

Sector -4.73

Industry -4.73

P/Total Assets

2.36

Sector 1.49

Industry 1.49

P/Net Current Assets

-9.58

Sector -11.70

Industry -11.70

P/Working Capital

21.72

Sector -3.19

Industry -3.19

EPS

-0.72

Sector -2.14

Industry -2.14

BVPS

0.52

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-137.04%

Sector -65.14%

Industry -65.14%

ROA

-49.09%

Sector -65.53%

Industry -65.53%

ROIC

-73.78%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.38

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.54

Sector -6.07

Industry -6.07

Net Debt / EBIT

2.45

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.04

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.36

Sector 0.41

Industry 0.41

Liabilities/Assets

0.64

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-9.86%

Sector -

Industry -

Fundamentals SANA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SANA Sana Biotechnology Inc.	$4.10	20.59%	0.00%	-4.81	6.59	-137.04%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SANA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Sana Biotechnology

Sana Biotechnology Inc.

Average Investor10 user rating

4.0 (1 people)

United States

8 years

Founded: 2018

2021

Time since IPO - 5 years

265

Employees

Sana Biotechnology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.02 billion, with shareholders equity totaling $154.57 million.

The company employs approximately 265 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Sana Biotechnology Inc. reported $- in revenue, generating net income of $-211.82 million.

Key financial metrics include a P/E ratio of -4.81, a price-to-book (P/B) ratio of 6.59, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SANA.

Market cap

$1.02 billion

Net worth

$154.57 million

$154,570,000.00

Assets

$431.52 million

$431,520,000.00

Total Shares Outstanding

296.00 million

296,000,000

Average Daily Trading Volume

$3.20 million

$3,200,919.64

Sector

Health Care

Industry

Biotechnology

SANA

SANA revenue and profits

Financial Results SANA

DRAG THE FRAME TO SEE MORE DATA

SANA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Sana Biotechnology (SANA) today?

A cotação de Sana Biotechnology (SANA) hoje está em US$ 4.10, com uma variação de 18.5% em relação ao último ano. A cotação de Sana Biotechnology (SANA) iniciou o ano negociando na casa dos US$ 4.07 e hoje está em US$ 4.10. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Sana Biotechnology (SANA) e dados de ações do Ibovespa e mercados internacionais.

Quando Sana Biotechnology (SANA) paga dividendos?

Sana Biotechnology (SANA) não distribuiu dividendos no último ano.

Is Sana Biotechnology (SANA) a good investment?

Atualmente, Sana Biotechnology (SANA) está cotada a US$ 4.10, com um P/L de -4.81, representando um desvio de -345% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 18.5 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 18.50%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Sana Biotechnology (SANA) stock?

Investir em ações de Sana Biotechnology (SANA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Sana Biotechnology (SANA) yield today?

A rentabilidade de Sana Biotechnology (SANA) foi de 27.33% no último mês, 18.50% no último ano e -81.78% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Sana Biotechnology (SANA) hoje, o investimento total seria de US$ 410.00, com base na cotação atual de US$ 4.10.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 485.85
Em 5 anos: US$ 74.70
Em 10 anos: US$ 410.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SANA

Sana Biotechnology Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SANA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SANA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Sana Biotechnology

Sana Biotechnology Inc.

United States

8 years

2021

265

PROFIT X PRICE SANA

Financial Results SANA

SANA cash flow

Asset, Revenue and Profit Growth - SANA

SANA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions